ImmunoPrecise Antibodies
Quarterly Financials
| Values in thousands | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
Revenue | $4,079 | $4,090 | $4,124 | $3,161 |
Gross Profit | 2,473 | 2,423 | 2,662 | 1,527 |
EBITDA | -4,055 | -3,670 | -2,987 | -3,237 |
EBIT | -4,291 | -3,883 | -3,194 | -4,179 |
Net Income | -3,831 | -3,865 | -3,195 | -2,959 |
Net Change In Cash | 4,079 | 4,090 | 4,124 | 3,161 |
Free Cash Flow | -2,522 | -2,955 | -2,944 | -4,495 |
Cash | 11,328 | 10,391 | 16,508 | 4,897 |
Basic Shares | 46,711 | 46,515 | 46,156 | 39,637 |
Annual Financials
| Values in thousands | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
Revenue | $15,319 | $24,520 | $24,518 | $20,665 |
Gross Profit | 9,007 | 13,548 | 12,053 | 11,563 |
EBITDA | -13,128 | -28,855 | -22,949 | -21,037 |
EBIT | -14,707 | -33,974 | -28,684 | -27,722 |
Net Income | -13,735 | -30,234 | -26,115 | -26,560 |
Net Change In Cash | 15,319 | 24,520 | 24,518 | 20,665 |
Free Cash Flow | -12,663 | -7,209 | -5,643 | -21,328 |
Cash | 11,328 | 10,665 | 3,459 | 8,280 |
Basic Shares | 46,381 | 33,385 | 25,636 | 24,897 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-04-30 | -$0.06 |
2026-01-31 | -$0.06 |
2025-10-31 | -$0.05 |
2025-07-31 | -$0.09 |